HSV1 VP1-2 deubiquitinates STING to block type I interferon expression and promote brain infection

0301 basic medicine 570 Cytoplasm Infectious disease and host defense Immunology 610 Innate immunity and inflammation Herpesvirus 1, Human Protein Serine-Threonine Kinases Article 03 medical and health sciences Animals Humans 11 Medical and Health Sciences Cells, Cultured Deubiquitinating Enzymes Ubiquitin Lysine Ubiquitination Brain Membrane Proteins Nucleotidyltransferases 3. Good health Mice, Inbred C57BL HEK293 Cells DNA, Viral Interferon Type I Mutation Microglia Signal Transduction
DOI: 10.1084/jem.20191422 Publication Date: 2020-05-08T13:24:01Z
ABSTRACT
Herpes simplex virus (HSV) is the main cause of viral encephalitis in the Western world, and the type I interferon (IFN) system is important for antiviral control in the brain. Here, we have compared Ifnb induction in mixed murine brain cell cultures by a panel of HSV1 mutants, each devoid of one mechanism to counteract the IFN-stimulating cGAS–STING pathway. We found that a mutant lacking the deubiquitinase (DUB) activity of the VP1-2 protein induced particularly strong expression of Ifnb and IFN-stimulated genes. HSV1 ΔDUB also induced elevated IFN expression in murine and human microglia and exhibited reduced viral replication in the brain. This was associated with increased ubiquitination of STING and elevated phosphorylation of STING, TBK1, and IRF3. VP1-2 associated directly with STING, leading to its deubiquitination. Recruitment of VP1-2 to STING was dependent on K150 of STING, which was ubiquitinated by TRIM32. Thus, the DUB activity of HSV1 VP1-2 is a major viral immune-evasion mechanism in the brain.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (61)
CITATIONS (74)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....